UroGen Pharma (URGN) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: URGN) | Delayed: 33.91 -0.13 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.04 | 52 Week High | $ | |||
| Open | $34.16 | 52 Week Low | $ | |||
| Day High | $34.50 | P/E | N/A | |||
| Day Low | $33.50 | EPS | $ | |||
| Volume | 1,033,088 | |||||
